# Atelerix Life Sciences Inc. — Form D

Atelerix Life Sciences Inc. of CHARLOTTESVILLE, VA, a company, filed a Form D exempt-offering notice with the SEC on 2022-10-03. The offering totals $3.5M, of which $650K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-10-03
- Form: D
- Accession: 0001948853-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.5M
- Amount sold: $650K
- Remaining: $2.9M
- Investors: 2
- Date of first sale: 2022-09-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-460533

## Issuer

- Name: Atelerix Life Sciences Inc.
- CIK: 0001948853
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 300 EAST MAIN STREET, CHARLOTTESVILLE, VA, 22902
- Phone: (434) 825-1834

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| William Akridge | Director | Charlottesville, VA |
| Peter Barton Hutt | Director | Salt Lake City, UT |
| David Kalergis | Director | Charlottesville, VA |
| David Kalergis | Executive Officer | Charlottesville, VA |
| David Kalergis | Promoter | Charlottesville, VA |

## More

- [CIK 1948853 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1948853&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001948853-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.